advisor-perspectives
Biotech IPO Gains Crush AI Listings With Standout 55% Return
By Anthony Hughes
The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.